Wisdom Pharmaceutical announced on November 10. Recently, Shanghai Ruizhi Pharmaceutical Research Group Co., Ltd., a wholly-owned subsidiary of the company, and East China Normal University successfully independently developed an automated, intelligent, and integrated desktop synthesis system for antibody-conjugated drugs and nucleotide monomers, which can achieve seamless connection and paradigm restructuring from laboratory R&D to industrial production. The use of automated, intelligent, and integrated desktop synthesis systems for ADC and nucleotide monomers can significantly shorten the R&D cycle, improve R&D efficiency, and help the company provide customers with better services.

Zhitongcaijing · 11/10/2025 11:01
Wisdom Pharmaceutical announced on November 10. Recently, Shanghai Ruizhi Pharmaceutical Research Group Co., Ltd., a wholly-owned subsidiary of the company, and East China Normal University successfully independently developed an automated, intelligent, and integrated desktop synthesis system for antibody-conjugated drugs and nucleotide monomers, which can achieve seamless connection and paradigm restructuring from laboratory R&D to industrial production. The use of automated, intelligent, and integrated desktop synthesis systems for ADC and nucleotide monomers can significantly shorten the R&D cycle, improve R&D efficiency, and help the company provide customers with better services.